I nvestors are struggling with a contradiction at the heart of the market as stocks move into their toughest months of the ...

The S&P 500 risks entering bubble territory once it passes a key threshold, according to strategists at SocGen, and Fed rate ...

Palantir stock surges in pre-market after crushing earnings estimates, boosting Nasdaq 100 and tech stock forecasts across US ...

North Chicago, Illinois-based AbbVie Inc. (ABBV) is a research-based biopharmaceutical company. Valued at a market cap of $348.3 billion, it researches, develops, manufactures, and markets innovative ...

Earnings are in the midst of a "rolling recovery" that'll boost the S&P 500. AI, fiscal policy, and rate cuts will help the ...

Palantir reported more than 50% growth in earnings from U.S. government contracts last quarter, boosted by the White House's push for cost-cutting and adoption of artificial-intelligence technology.

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

With Wall Street's surge to record highs, the U.S. stock market looks nearly as expensive as ever, and investors are debating whether the lofty valuations are a bearish signal or justified by the ...

Due to Philip Morris’s strong performance relative to the broader market over the past year, Wall Street analysts maintain a strongly optimistic outlook on the stock’s prospects.